Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias.
D000284:Administration, Oral; D000328:Adult; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D001283:Atrioventricular Node / Q000503:physiopathology; D005260:Female; D006325:Heart Atria / Q000503:physiopathology; D006352:Heart Ventricles / Q000503:physiopathology; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D013610:Tachycardia / Q000150:complications / Q000188:drug therapy*; D013997:Time Factors; D014700:Verapamil / Q000627:therapeutic use*; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications
D014700:Verapamil